
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $168.1M | -- | -- | $1.00 | -- |
08/08/2025 | Q2 | $182.5M | -- | -- | $1.02 | -- |
05/07/2025 | Q1 | $248.4M | $298.7M | $2.21 | $2.25 | -$0.04 |
02/26/2025 | Q4 | $237.8M | $215M | $1.60 | $1.64 | -$0.03 |
11/07/2024 | Q3 | $171.9M | $160.1M | $0.78 | $0.67 | $0.11 |
08/08/2024 | Q2 | $194.7M | $166.3M | $0.82 | $0.81 | $0.01 |
05/08/2024 | Q1 | $278.6M | $245.7M | $2.07 | $2.14 | -$0.07 |
02/21/2024 | Q4 | $234.6M | $185.3M | $1.26 | $1.56 | -$0.30 |
11/02/2023 | Q3 | $143.2M | $131.5M | $0.53 | $0.63 | -$0.10 |
08/03/2023 | Q2 | $158.2M | $135.6M | $0.90 | $0.96 | -$0.06 |
05/03/2023 | Q1 | -- | $218.1M | $2.04 | -- | -- |
02/22/2023 | Q4 | -- | $187.3M | $1.47 | -- | -- |
11/02/2022 | Q3 | -- | $131.1M | $0.54 | -- | -- |
08/03/2022 | Q2 | -- | $139.5M | $0.96 | -- | -- |
05/03/2022 | Q1 | -- | $222.9M | $2.08 | -- | -- |
02/23/2022 | Q4 | -- | $160.4M | $1.28 | -- | -- |
11/03/2021 | Q3 | -- | $107.3M | $0.71 | -- | -- |
08/04/2021 | Q2 | -- | $111.1M | $0.78 | -- | -- |
05/04/2021 | Q1 | -- | $191.2M | $1.96 | -- | -- |
02/24/2021 | Q4 | -- | $137M | $1.28 | -- | -- |
11/04/2020 | Q3 | -- | $101.4M | $0.56 | -- | -- |
08/05/2020 | Q2 | -- | $97.1M | $0.66 | -- | -- |
05/06/2020 | Q1 | -- | $152.7M | $1.76 | -- | -- |
02/26/2020 | Q4 | -- | $132M | $1.37 | -- | -- |
11/07/2019 | Q3 | -- | $92.6M | $0.34 | -- | -- |
08/08/2019 | Q2 | -- | $94.5M | $0.50 | -- | -- |
05/08/2019 | Q1 | -- | $160.5M | $1.74 | -- | -- |
02/26/2019 | Q4 | -- | $134.2M | $1.08 | -- | -- |
11/08/2018 | Q3 | -- | $93.4M | $0.34 | -- | -- |
08/09/2018 | Q2 | -- | $136.7M | $0.39 | -- | -- |
05/09/2018 | Q1 | -- | $239.4M | $1.64 | -- | -- |
02/28/2018 | Q4 | -- | $12.5M | $1.59 | -- | -- |
11/09/2017 | Q3 | -- | $126.9M | $0.42 | -- | -- |
08/03/2017 | Q2 | -- | $125.1M | $0.37 | -- | -- |
05/03/2017 | Q1 | -- | $185.2M | $1.17 | -- | -- |
02/28/2017 | Q4 | -- | $141.9M | $0.73 | -- | -- |
11/03/2016 | Q3 | -- | $108.3M | $0.29 | -- | -- |
08/04/2016 | Q2 | -- | $102.3M | $0.52 | -- | -- |
05/04/2016 | Q1 | -- | $146.3M | $1.33 | -- | -- |
02/25/2016 | Q4 | -- | $104.6M | $0.56 | -- | -- |
11/05/2015 | Q3 | -- | $91.9M | $0.33 | -- | -- |
Chesapeake Utilities reported $298.7M worth of top line sales in its most recent quarter.
Chesapeake Utilities announced earnings per share of $2.21 which represents a miss of analyst forecast a $2.25 per share.
Chesapeake Utilities reported $119M that represents $5.16 per share over the last quarter.
Chesapeake Utilities's earnings are forecast to grow from $5.26 per share to $5.39 per share next year representing an increase of 18.7%.
Chesapeake Utilities's next earnings date is August 8, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.